| Literature DB >> 33897159 |
Rajendra K Shimpi1, Darshan N Patel1, Krutik Raval1, Priyank Shah1, Bonny Shah1.
Abstract
PURPOSE: Orthotopic neobladder is a well-established technique for continent urinary diversion after radical cystectomy. In this study, we evaluated a new Frog ileal neobladder technique. Since the reconstructed neobladder appears like a frog, the name Frog Neobladder was given to it. We have used two isoperistaltic ileal segments and implanted ureters in the nondetubularized proximal end of the ileal segment. SUBJECTS AND METHODS: This was a prospective, single-center (tertiary care hospital) study conducted from February 2008 to January 2018. Study patients were aged 39-94 years with biopsy-proven muscle-invasive localized bladder carcinoma. One hundred and twenty patients were included in the study, who had undergone Radical Cystectomy and were offered "FROG BLADDER"- a type of neobladder. Evaluation of complications, renal function, urodynamic parameters, post-void residual urine (PVR), continence, and need for clean intermittent catheterization was done in all patients with neobladder.Entities:
Keywords: Carcinoma bladder; FROG neobladder; neobladder; orthotopic
Year: 2021 PMID: 33897159 PMCID: PMC8052909 DOI: 10.4103/UA.UA_119_19
Source DB: PubMed Journal: Urol Ann ISSN: 0974-7796
Figure 1FROG neobladder (arrow showing nondetubularized proximal ileal segment-horn of neobladders, for uretero-ileal anastomosis
Figure 2Completed FROG ileal neobladder with supra-pubic catheter (SPC) in situ (arrows showing horn of ileal neobladder, which resembles legs of sitting FROG from above
Perioperative and follow-up evaluation of different parameters (n=120)
| Parameter | Results |
|---|---|
| Age (years), mean | 61 |
| Operative time (min) | 280±29.8 |
| Complications, | |
| Early | 37 (31.2) |
| Late | 22.4 (18.7) |
| At 1-year follow-up | |
| Maximum neobladder capacity (ml) | |
| 6 months | 256±167 |
| 1 year | 398±220 |
| 3 years | 412±215 |
| Pressure at maximum capacity (cm of H2O) | 13±6.2 |
| Maximum flow rate (ml/s) | 14.4±8.7 |
| Postvoid residue (ml) | 46±54.4 |
| Continence, | |
| Daytime | 109 (90.1) |
| Nighttime | 105 (87.5) |
| CISC rate, | 3 (2.5) |
| Urethral/pelvic recurrence, | 12 (10) |
| Creatinine | |
| Preoperative | 0.9±0.24 |
| Postoperative | 1.0±0.45 |
CISC: Clean intermittent catheterization